Clinical trial

Does Immediate Lymphatic Reconstruction Decrease the Risk of Lymphedema After Axillary Lymph Node Dissection

NCT04241341

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2020-01-22

PhasePHASE3

Study timeline

Study start (actual)2020-01-22Date precision: day

Registry last updated2026-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Lymphedemaunresolved

Interventions

Axillary Lymph Node Dissection with Immediate Lymphatic ReconstructionPROCEDURE

Axillary Lymph Node Dissection without Immediate Lymphatic ReconstructionPROCEDURE

quality-of-life questionnairesOTHER

measured by arm volumeOTHER

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Mapped research locations

New YorkNew York, United States1 CommackNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04241341 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.